Frontage Holdings

Frontage Holdings Corporation is a contract research organization that offers a range of research, analytical, and development services to pharmaceutical, biotechnology, and agrochemical companies. The company specializes in laboratory services that facilitate drug discovery and development, including drug metabolism, pharmacokinetics, safety and toxicology, and bioanalytical services. Additionally, it provides support in chemistry, manufacturing, controls, agrochemical services, and clinical study-related services. Frontage operates primarily in the United States and Canada, with a significant presence in the People’s Republic of China, as well as operations in Europe, India, Japan, Korea, Israel, and Australia. Established in 2018 and headquartered in Exton, Pennsylvania, Frontage Holdings is a subsidiary of Hong Kong Tigermed Co., Limited, generating most of its revenue from the United States, followed by the PRC and other global markets.